This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Corrigendum to "Mefloquine targets β-catenin pathway and thus can play a role in the treatment of liver cancer" [Microb. Pathogen. 118 (2018) 357-360]. (November 2021)
Record Type:
Journal Article
Title:
Corrigendum to "Mefloquine targets β-catenin pathway and thus can play a role in the treatment of liver cancer" [Microb. Pathogen. 118 (2018) 357-360]. (November 2021)
Main Title:
Corrigendum to "Mefloquine targets β-catenin pathway and thus can play a role in the treatment of liver cancer" [Microb. Pathogen. 118 (2018) 357-360]